Based on recent data, BioLineRx Ltd. (BLRX) shows an Average True Range (ATR) of 0.17 and an Enterprise Value of 59.43M. Its average trading volume over the past 3 months is 17.27K, indicating liquidity. These fundamental metrics provide insight into BLRX's underlying financial health and market activity.
| ATR | 0.17 |
| Enterprise Value | 59.43M |
| Avg Vol (3 Months) | 17.27K |
| Avg Vol (10 Days) | 66.15K |
BioLineRx Ltd. (BLRX) technical indicators as of May 2, 2026: the SMA 20 is -2.09%, SMA 50 at -1.99%, and SMA 200 at -21.62%. The RSI 14 value is 47.37, suggesting its current momentum. These technical analysis signals help assess BLRX's price trends and potential future movements.
| SMA 20 | -2.09% |
| SMA 50 | -1.99% |
| SMA 200 | -21.62% |
| RSI 14 | 47.37 |
BioLineRx Ltd. (BLRX) stock performance overview as of May 2, 2026: The 52-week high is $7.77 (currently -62.93% below), and the 52-week low is $2.15 (currently 25.21% above). Over the past year, BLRX's performance is -41.96%, compared to the S&P 500's 17.86% change.
| 52-Week High | 7.77 |
| 52-Week High Chg | -62.93% |
| 52-Week Low | 2.15 |
| 52-Week Low Chg | +25.21% |
| S&P 500 52-Week Chg | 17.86% |
According to market data, BioLineRx Ltd. (BLRX) stock's recent performance metrics show that over the last month, BLRX is -5.03%, with a Year-to-Date (YTD) performance of 2.17%. Over the past year, the stock has seen a -41.96% change. These figures summarize BLRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 3.17 | 3.17 | 3.2 | 3.9 | 7.77 | 3.2 |
| Low | 2.23 | 2.15 | 2.15 | 2.15 | 2.15 | 2.15 |
| Performance | -1.05% | -5.03% | -24.13% | -35.09% | -41.96% | +2.17% |
According to current financial data, BLRX stock's P/E (TTM) ratio is -10.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for BLRX, including P/S (10.08), P/B (0.65), and P/FCF (-1.46), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BLRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -10.05 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 10.08 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 0.65 | 3.75 | 1.01 | 4.72 |
| P/FCF (TTM) | -1.46 | 248.01 | -462.17 | 32.8 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep